ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2026

SGLT2 Inhibitors in Cardiovascular-Kidney-Metabolic Syndrome: Drugs Unifying Heart, Kidney, and Metabolism Pharmacotherapy.

Valentina Okhovat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.